Some figures are taken from previous publications.
EBITDA= earnings before interest, tax, depreciation and amortization.
* Calculated based on exchange rate SEK-EUR as of December 31, 2021.
The EBITDA of Swedish pharmaceutical company Recipharm generally increased, but with some fluctuations, during the period from 2009 to 2021. In 2009, EBITDA amounted to 61.1 million Swedish kronor, and in 2021, the company reported the highest EBITDA so far, with some 2.08 billion Swedish kronor. Recipharm is a Swedish pharmaceutical contract development and manufacturing organization, founded in Stockholm in 1995.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Recipharm. (March 14, 2022). EBITDA of Recipharm from 2009 to 2021 (in million SEK) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 25, 2026, from /statistics/947068/operating-profit-ebit-of-recipharm/
Recipharm. "EBITDA of Recipharm from 2009 to 2021 (in million SEK) ." Chart. March 14, 2022. ÌÇÐÄÆÆ½â°æ. Accessed July 25, 2026. /statistics/947068/operating-profit-ebit-of-recipharm/
Recipharm. (2022). EBITDA of Recipharm from 2009 to 2021 (in million SEK) . ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 25, 2026. /statistics/947068/operating-profit-ebit-of-recipharm/
Recipharm. "Ebitda of Recipharm from 2009 to 2021 (in Million Sek) ." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 14 Mar 2022, /statistics/947068/operating-profit-ebit-of-recipharm/
Recipharm, EBITDA of Recipharm from 2009 to 2021 (in million SEK) ÌÇÐÄÆÆ½â°æ, /statistics/947068/operating-profit-ebit-of-recipharm/ (last visited July 25, 2026)
EBITDA of Recipharm from 2009 to 2021 (in million SEK) [Graph], Recipharm, March 14, 2022. [Online]. Available: /statistics/947068/operating-profit-ebit-of-recipharm/